Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Annals of the Rheumatic Diseases
|
November 6, 2019
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
Maxime Dougados, James Cheng-Chung Wei, Robert Landewé, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
Systematic Engineering of Intra-Articular Drug Release Profiles Reveals a Key Determinant of Disease-Modifying Efficacy in Post-Traumatic Osteoarthritis
Jingjing Gao, Nutan Bhingaradiya, Ziting Judy Xia, et al.
The American Journal of Gastroenterology
|
January 6, 2025
Prevalence and Risk Factors of Spondyloarthritis Symptoms in a US-Based Multicenter Cohort of Patients With Inflammatory Bowel Disease
Simon J Hong, Rahul S Dalal, Kristine A Kuhn, et al.
Arthritis Care & Research
|
January 3, 2025
Frequency of Spondyloarthritis Symptoms Among US Patients With Inflammatory Bowel Disease: A Cross-Sectional Multi-Center Study
Joerg Ermann, Simon J Hong, Andrew Stahly, et al.
Science Translational Medicine
|
October 19, 2018
Mixed-effects association of single cells identifies an expanded effector CD4<sup>+</sup> T cell subset in rheumatoid arthritis
Chamith Y Fonseka, Deepak A Rao, Nikola C Teslovich, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 8, 2021
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease
Joerg Ermann, Mederbek Matmusaev, Emma K Haley, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
A Mechanically Resilient Soft Hydrogel Improves Drug Delivery for Treating Post-Traumatic Osteoarthritis in Physically Active Joints
Nitin Joshi, Jing Yan, Mickael Dang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 31, 2025
A mechanically resilient soft hydrogel improves drug delivery for treating post-traumatic osteoarthritis in physically active joints
Nitin Joshi, Jing Yan, Mickael Dang, et al.
Arthritis Care & Research
|
September 25, 2015
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M Ward, Atul Deodhar, Elie A Akl, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 25, 2015
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M Ward, Atul Deodhar, Elie A Akl, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Annals of the Rheumatic Diseases
|
November 6, 2019
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
Maxime Dougados, James Cheng-Chung Wei, Robert Landewé, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
Systematic Engineering of Intra-Articular Drug Release Profiles Reveals a Key Determinant of Disease-Modifying Efficacy in Post-Traumatic Osteoarthritis
Jingjing Gao, Nutan Bhingaradiya, Ziting Judy Xia, et al.
The American Journal of Gastroenterology
|
January 6, 2025
Prevalence and Risk Factors of Spondyloarthritis Symptoms in a US-Based Multicenter Cohort of Patients With Inflammatory Bowel Disease
Simon J Hong, Rahul S Dalal, Kristine A Kuhn, et al.
Arthritis Care & Research
|
January 3, 2025
Frequency of Spondyloarthritis Symptoms Among US Patients With Inflammatory Bowel Disease: A Cross-Sectional Multi-Center Study
Joerg Ermann, Simon J Hong, Andrew Stahly, et al.
Science Translational Medicine
|
October 19, 2018
Mixed-effects association of single cells identifies an expanded effector CD4<sup>+</sup> T cell subset in rheumatoid arthritis
Chamith Y Fonseka, Deepak A Rao, Nikola C Teslovich, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
September 8, 2021
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease
Joerg Ermann, Mederbek Matmusaev, Emma K Haley, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
A Mechanically Resilient Soft Hydrogel Improves Drug Delivery for Treating Post-Traumatic Osteoarthritis in Physically Active Joints
Nitin Joshi, Jing Yan, Mickael Dang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 31, 2025
A mechanically resilient soft hydrogel improves drug delivery for treating post-traumatic osteoarthritis in physically active joints
Nitin Joshi, Jing Yan, Mickael Dang, et al.
Arthritis Care & Research
|
September 25, 2015
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M Ward, Atul Deodhar, Elie A Akl, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 25, 2015
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M Ward, Atul Deodhar, Elie A Akl, et al.
Page
of 8